This HTML5 document contains 20 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

PrefixNamespace IRI
dbpedia-owlhttp://dbpedia.org/ontology/
foafhttp://xmlns.com/foaf/0.1/
n8http://www.seattlegenetics.com/
rdfshttp://www.w3.org/2000/01/rdf-schema#
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n6http://dbpedia.org/resource/Bothell,
xsdhhttp://www.w3.org/2001/XMLSchema#
n4http://dbpedia.org/resource/Washington_(state)
dbpediahttp://dbpedia.org/resource/
Subject Item
dbpedia:Seattle_Genetics
rdfs:comment
Seattle Genetics is a biotechnology company focused on developing and commercializing innovative, empowered monoclonal antibody-based therapies for the treatment of cancer. The company, headquartered in Bothell, Washington (a suburb of Seattle), is the industry leader in antibody-drug conjugates or ADCs, a technology designed to harness the targeting ability of monoclonal antibodies to deliver cell-killing agents directly to cancer cells.
foaf:name
Seattle Genetics
foaf:homepage
n8:
dbpedia-owl:foundingDate
1997-07-15Z
dbpedia-owl:foundingYear
1997-01-01Z
dbpedia-owl:industry
dbpedia:Biotechnology dbpedia:Pharmaceutical_drug
dbpedia-owl:keyPerson
dbpedia:Chief_Medical_Officer dbpedia:Chief_executive_officer dbpedia:Chief_financial_officer dbpedia:Chairman dbpedia:Chief_operating_officer dbpedia:Vice_president
dbpedia-owl:location
n4: n6:_Washington dbpedia:United_States
dbpedia-owl:numberOfEmployees
650
dbpedia-owl:product
dbpedia:Brentuximab_vedotin dbpedia:Antibody-drug_conjugate
dbpedia-owl:type
dbpedia:Public_company